Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$111.51 0.22 (0.2%) as of 4:30 Wed 7/2


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 139.39(B)
Last Volume: 5,991,160 Avg Vol: 8,500,520
52 Week Range: $66.59 - $117.41
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  425
Guru Rank Value     : 4.8
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 48,500 353,785 880,125 919,098
Total Sell Value $5,236,242 $36,015,844 $83,946,002 $87,021,111
Total People Sold 3 3 5 5
Total Sell Transactions 6 12 23 32
End Date 2025-04-03 2024-12-31 2024-07-02 2023-07-03

   
Records found: 179
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-11-29 4 AS $92.76 $23,065,271 D/D (248,645) 138,919 12%     
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-11-29 4 OE $57.92 $17,528,577 D/D 248,645 387,564     -
   Parsey Merdad Chief Medical Officer   •       •      –    2024-11-27 4 S $91.79 $15,094,013 D/D (164,211) 80,801 -10%     
   Parsey Merdad Chief Medical Officer   •       •      –    2024-11-27 4 OE $57.92 $9,079,689 D/D 145,413 245,012     -
   Bluestone Jeffrey Director   •       •      –    2024-11-26 4 S $91.39 $620,356 D/D (6,788) 8,920 -15%     
   Bluestone Jeffrey Director   •       •      –    2024-11-26 4 OE $61.17 $612,442 D/D 10,000 15,708     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-11-06 4 AS $91.28 $456,400 D/D (5,000) 73,127 15%     
   Parsey Merdad Chief Medical Officer   •       •      –    2024-11-06 4 AS $91.50 $2,341,485 D/D (25,590) 99,599 15%     
   Parsey Merdad Chief Medical Officer   •       •      –    2024-11-06 4 OE $57.92 $1,448,000 D/D 25,000 125,189     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-10-25 4 D $89.00 $21,538 D/D (242) 20,979     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-10-25 4 OE $0.00 $0 D/D 514 21,221     -
   Parsey Merdad Chief Medical Officer   •       •      –    2024-10-01 4 AS $83.83 $167,660 D/D (2,000) 100,189 15%     
   Parsey Merdad Chief Medical Officer   •       •      –    2024-09-12 4 AS $84.50 $1,795,287 D/D (21,246) 102,189 12%     
   Parsey Merdad Chief Medical Officer   •       •      –    2024-09-12 4 OE $57.92 $1,448,000 D/D 25,000 123,435     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-09-12 4 AS $83.25 $2,459,577 D/D (29,357) 78,127 12%     
   Oday Daniel Patrick Chairman & CEO   •       •      –    2024-09-10 4 D $81.44 $386,759 D/D (4,749) 495,995     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2024-09-10 4 OE $0.00 $0 D/D 10,295 500,744     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-09-10 4 D $81.44 $141,217 D/D (1,734) 107,484     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-09-10 4 OE $0.00 $0 D/D 3,752 109,218     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-09-10 4 D $81.44 $25,002 D/D (307) 20,707     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-09-10 4 OE $0.00 $0 D/D 639 21,014     -
   Patterson Sandra SVP, Controllership   •       •      –    2024-09-10 4 D $81.44 $23,780 D/D (292) 36,585     -
   Patterson Sandra SVP, Controllership   •       •      –    2024-09-10 4 OE $0.00 $0 D/D 901 36,877     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-09-10 4 D $81.44 $136,982 D/D (1,682) 138,919     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-09-10 4 OE $0.00 $0 D/D 3,641 140,601     -
  179 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us